Genome-wide analysis of STAT target genes - Elucidating the mechanism of STAT-mediated oncogenesis

被引:91
作者
Alvarez, JV
Frank, DA
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
关键词
STAT3; STAT5; STAT; transcription factor; cancer; oncogenesis; microarray; expression profiling;
D O I
10.4161/cbt.3.11.1172
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Inappropriate activation of transcription factors is a common event in cancer. These transcription factors contribute to a malignant phenotype by regulating genes involved in cellular proliferation, survival, differentiation, angiogenesis, and invasion. An important goal remains identifying the targets of oncogenic transcription factors that execute these changes. STAT proteins are among the best-studied of these transcription factors, and are involved in oncogenesis both in vivo and in vitro. They thus represent an ideal model for understanding how transcription factors cause cancer through coordinated changes in gene expression. Recent studies have employed microarray-based expression analysis to comprehensively identify STAT target genes. Analysis of these targets can provide insight into mechanisms of neoplastic transformation, and may shed light on new strategies for targeted therapy.
引用
收藏
页码:1045 / 1050
页数:6
相关论文
共 55 条
  • [11] Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C
    Dechow, TN
    Pedranzini, L
    Leitch, A
    Leslie, K
    Gerald, WL
    Linkov, I
    Bromberg, JF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (29) : 10602 - 10607
  • [12] IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line
    Dumon, S
    Santos, SCR
    Debierre-Grockiego, F
    Gouilleux-Gruart, V
    Cocault, L
    Boucheron, C
    Mollat, P
    Gisselbrecht, S
    Gouilleux, F
    [J]. ONCOGENE, 1999, 18 (29) : 4191 - 4199
  • [13] Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression
    Epling-Burnette, PK
    Liu, JH
    Catlett-Falcone, R
    Turkson, J
    Oshiro, M
    Kothapalli, R
    Li, YX
    Wang, JM
    Yang-Yen, HF
    Karras, J
    Jove, R
    Loughran, TP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (03) : 351 - 361
  • [14] Frank DA, 1999, MOL MED, V5, P432
  • [15] Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis
    Fukada, T
    Hibi, M
    Yamanaka, Y
    TakahashiTezuka, M
    Fujitani, Y
    Yamaguchi, T
    Nakajima, K
    Hirano, T
    [J]. IMMUNITY, 1996, 5 (05) : 449 - 460
  • [16] STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition
    Fukada, T
    Ohtani, T
    Yoshida, Y
    Shirogane, T
    Nishida, K
    Nakajima, K
    Hibi, M
    Hirano, T
    [J]. EMBO JOURNAL, 1998, 17 (22) : 6670 - 6677
  • [17] Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells
    Garcia, R
    Bowman, TL
    Niu, GL
    Yu, H
    Minton, S
    Muro-Cacho, CA
    Cox, CE
    Falcone, R
    Fairclough, R
    Parsons, S
    Laudano, A
    Gazit, A
    Levitzki, A
    Kraker, A
    Jove, R
    [J]. ONCOGENE, 2001, 20 (20) : 2499 - 2513
  • [18] The Stat family in cytokine signaling
    Ihle, JN
    [J]. CURRENT OPINION IN CELL BIOLOGY, 2001, 13 (02) : 211 - 217
  • [19] Cooperation between STAT3 and c-Jun suppresses Fas transcription
    Ivanov, VN
    Bhoumik, A
    Krasilnikov, M
    Raz, R
    Owen-Schaub, LB
    Levy, D
    Horvath, CM
    Ronai, Z
    [J]. MOLECULAR CELL, 2001, 7 (03) : 517 - 528
  • [20] Puma is an essential mediator of p53-dependent and -independent apoptotic pathways
    Jeffers, JR
    Parganas, E
    Lee, Y
    Yang, CY
    Wang, JL
    Brennan, J
    MacLean, KH
    Han, JW
    Chittenden, T
    Ihle, JN
    McKinnon, PJ
    Cleveland, JL
    Zambetti, GP
    [J]. CANCER CELL, 2003, 4 (04) : 321 - 328